PDCD1 and neoplasm: We speculate that tumor-infiltrating PD-1Neg CD8+ T cells represent an earlier phase of effector differentiation compared to PD-1 expressing tumor-infiltrating CD8+ T cells and would therefore be predicted to have effector potential and capacity to sustain long-lasting immunity.